Vasorelaxant effects of pramanicin, an anti-fungal agent: Selective action on endothelial cells

Japanese Journal of Pharmacology

Volumn 85, Issue 3, 2001, Pages 234-240

  Kwan, C Y ^a   Harrison, P H M ^a   Duspara, P A ^a   Daniel, E E ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Antifungal agent; Endothelial cell; Nitric oxide; Pramanicin; Vascular smooth muscle

Indexed keywords

ANTIFUNGAL AGENT; CALCIUM ION; CARBACHOL; N(G) NITROARGININE; NITRIC OXIDE; PHENYLEPHRINE; PRAMANICIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENDOTHELIUM CELL; EXTRACELLULAR CALCIUM; FEMALE; IN VITRO STUDY; INHIBITION KINETICS; MALE; MEDIATOR; NONHUMAN; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE RELAXATION; STRUCTURE ANALYSIS; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0035072017     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.85.234     Document Type: Article

References (19)

1. The structure of lipoxamycin, a novel antifungal antibiotic
2. Papulacandins, a new family of antibiotics with antifungal activity, I. Fermentation, isolation, chemical and biological characterization of papulacandins A, B, C, D and E
3. Restricticin, a novel glycine-containing antifungal agent
4. Pneumocandins from Zalerion arboricola. I. Discovery and isolation
5. Sphingofungins A, B, C, and D; A new family of antifungal agents. I. Fermentation, isolation, and biological activity
6. 2+ ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles
7. 2+ transport by cyclopiazonic acid and thapsigargin in smooth muscle microsomes
8. 2+ transport ATPase by thapsigargin at subnanomolar concentrations
9. 2+ pool in vascular smooth muscle
10. Pramanicin, a novel antimicrobial agent form a fungal fermentation
11. The biosynthesis of pramanicin: Origin of the carbon skeleton
12. G-nitro-arginine, a novel L-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro
13. Nitric oxide: Pathophysiological mechanisms
14. 2+ in EDRF release in rat aorta
15. The role of calcium in endothelium-dependent relaxation of arterial smooth muscle
16. i regulation in apoptosis, oncosis and necrosis
17. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins
18. Lysolecithins as endothelium-dependent vascular smooth muscle relaxants that differ from endothelium-derived relaxing factor (nitric oxide)
19. Perturbation by lysophosphatidylcholine of membrane permeability in cultured vascular smooth muscle and endothelial cells